Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1745-6215
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial ; volume:17 ; number:1 ; day:20 ; month:7 ; year:2016 ; pages:1-10 ; date:12.2016
Trials ; 17, Heft 1 (20.7.2016), 1-10, 12.2016

Urheber
Doyle, Mary-Anne
Beteiligte Personen und Organisationen
Singer, Joel
Lee, Terry
Muir, Miriam
Cooper, Curtis
SpringerLink (Online service)

DOI
10.1186/s13063-016-1454-6
URN
urn:nbn:de:1111-20160723661
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:53 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Doyle, Mary-Anne
  • Singer, Joel
  • Lee, Terry
  • Muir, Miriam
  • Cooper, Curtis
  • SpringerLink (Online service)

Ähnliche Objekte (12)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

MicroRNA signature from extracellular vesicles of HCV/HIV co-infected individuals differs from HCV mono-infected

Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV

Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg

Screening of differentially expressed gene in HIV/HCV co-infected patients

Screening of differentially expressed gene in HIV/HCV co-infected patients

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Immune response characterization in HIV/HCV co-infected patients of medicine tropical foundation

Immune response characterization in HIV/HCV co-infected patients of medicine tropical foundation

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord

Metabolic features in chronic HCV infected patients

Metabolic features in chronic HCV infected patients

Verbundene Objekte